Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

Eastell, Richard, Black, Dennis M, Boonen, Steven, Adami, Silvano, Felsenberg, Dieter, Lippuner, Kurt, Cummings, Steven R., Delmas, Pierre D., Palermo, Lisa, Mesenbrink, Peter, Cauley, Jane A., Fracture Trial, Horizon Pivotal and Fraser, W. D. (2009) Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density. The Journal of Clinical Endocrinology and Metabolism, 94 (9). pp. 3215-3225. ISSN 0021-972X

Full text not available from this repository. (Request a copy)

Abstract

ZOL appeared more effective in preventing vertebral fracture in younger women, overweight/obese women, and women with normal renal function. ZOL had similar effects irrespective of fracture risk factors or femoral neck BMD.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Musculoskeletal Medicine Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	Rhiannon Harvey
Date Deposited:	11 May 2011 08:51
Last Modified:	19 Oct 2023 00:37
URI:	https://ueaeprints.uea.ac.uk/id/eprint/30178
DOI:	10.1210/jc.2008-2765

Actions (login required)

View Item